ArticlePharmacoEconomics2019

Economic Evaluation of the 2016 Chinese Guideline and Alternative Risk Thresholds of Initiating Statin Therapy for the Management of Atherosclerotic Cardiovascular Disease.

Yawen Jiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.